These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1621085)

  • 21. Successful management of malignant hyperthermia susceptibility during cesarean hysterectomy for postpartum hemorrhage.
    Wu YC; Ho CM; Tsou MY; Hung JH; Yuan CC; Lee TY; Ng HT
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):738-9. PubMed ID: 10468070
    [No Abstract]   [Full Text] [Related]  

  • 22. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry.
    Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR
    Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recommendations on malignant hyperthermia. Gruppo di Studio SAARTI per la Sicurezza in Anestesia e Terapia Intensiva].
    Minerva Anestesiol; 1997 Sep; 63(9):279-85. PubMed ID: 9542388
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
    Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
    Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Atypical malignant hyperthermia. A higher incidence than expected].
    Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
    [No Abstract]   [Full Text] [Related]  

  • 26. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting susceptibility to malignant hyperthermia.
    Ellis FR
    BMJ; 1992 Mar; 304(6830):791-2. PubMed ID: 1392703
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroleptic malignant syndrome and malignant hyperthermia susceptibility.
    Tweed WA
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):605. PubMed ID: 2244451
    [No Abstract]   [Full Text] [Related]  

  • 29. Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment.
    Guis S; Jouglard J; Kozak-Ribbens G; Figarella-Branger D; Vanuxem D; Pellissier JF; Cozzone PJ
    J Rheumatol; 2001 Jun; 28(6):1405-6. PubMed ID: 11409139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A medical student with malignant hyperthermia susceptibility.
    Underwood N; Austin JD
    Anaesth Intensive Care; 2012 Mar; 40(2):356. PubMed ID: 22417041
    [No Abstract]   [Full Text] [Related]  

  • 31. Susceptibility to malignant hyperthermia.
    Gronert GA
    Anesth Analg; 1984 Jan; 63(1):91-2. PubMed ID: 6691574
    [No Abstract]   [Full Text] [Related]  

  • 32. Predicting malignant hyperthermia.
    Ellis FR
    Br J Anaesth; 1990 Apr; 64(4):411-2. PubMed ID: 2334613
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosing malignant hyperthermia susceptibility.
    Hopkins PM; Halsall PJ; Ellis FR
    Anaesthesia; 1994 May; 49(5):373-5. PubMed ID: 8209973
    [No Abstract]   [Full Text] [Related]  

  • 34. Sensitivity and specificity of tests of malignant hyperthermia susceptibility.
    Hackmann T
    Anesth Analg; 1991 Aug; 73(2):233. PubMed ID: 1854040
    [No Abstract]   [Full Text] [Related]  

  • 35. Spin resonance spectroscopy to detect malignant hyperthermia susceptibility.
    Buckmaster HA; Kerr KA; Kudynska J
    Br J Anaesth; 1993 May; 70(5):598-9. PubMed ID: 8391293
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant hyperthermia. Preoperative assessment of risk factors.
    Smith RJ
    Br J Anaesth; 1988 Feb; 60(3):317-9. PubMed ID: 3279992
    [No Abstract]   [Full Text] [Related]  

  • 37. Susceptibility to malignant hyperthermia detected non-invasively.
    Payen JF; Bourdon L; Mezin P; Jacquot C; le Bas JF; Stieglitz P; Benabid AL
    Lancet; 1991 Jun; 337(8756):1550-1. PubMed ID: 1675403
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential value of expiratory carbon dioxide measurement in patients considered to be susceptible to malignant hyperthermia.
    Triner L; Sherman J
    Anesthesiology; 1981 Oct; 55(4):482. PubMed ID: 6794386
    [No Abstract]   [Full Text] [Related]  

  • 39. Malignant hyperthermia.
    Anido V
    South Med J; 1976 Sep; 69(9):1247. PubMed ID: 968553
    [No Abstract]   [Full Text] [Related]  

  • 40. Malignant hyperthermia. An historical vignette.
    Harrison GG; Isaacs H
    Anaesthesia; 1992 Jan; 47(1):54-6. PubMed ID: 1536407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.